Schizophrenia with comorbid idiopathic parkinson's disease: A difficult clinical management scenario

Schizophrenia with comorbid idiopathic parkinson's disease: A difficult clinical management scenario

Comorbidity of idiopathic Parkinson's disease (IPD) and schizophrenia is an uncommon and rare scenario, which often poses a difficult and challenging situation for management. Both the disorders have completely opposite pathophysiology and treatment of one disorder with available pharmacologica...

Full description

Bibliographic Details
Main Authors:	Sandeep Grover, Swapnajeet Sahoo, Manoj Kumar Goyal
Format:	Article
Language:	English
Published:	SAGE Publishing 2017-01-01
Series:	Indian Journal of Psychological Medicine
Subjects:	Management Parkinson's disease schizophrenia
Online Access:	http://www.ijpm.info/article.asp?issn=0253-7176;year=2017;volume=39;issue=6;spage=823;epage=827;aulast=Grover

Similar Items

Idiopathic Parkinson’s disease and Schizophrenia: Dilemma in diagnosis and treatment
by: Sneha Sharma, et al.
Published: (2019-05-01)

Psychotic symptoms in patients with Parkinson's disease: A case report and overview of management
by: Swapnajeet Sahoo, et al.
Published: (2017-01-01)

The correlation between osteoporosis occurrences in both schizophrenia and Parkinson’s disease
by: Fatemeh eRadaei, et al.
Published: (2014-06-01)

Transtorno esquizoafetivo e doença de Parkinson: uma comorbidade possível? Schizoaffective disorder and Parkinson’s disease: a possible comorbidity?
by: Arthur Kümmer, et al.
Published: (2006-01-01)

Shared Genetic Background between Parkinson’s Disease and Schizophrenia: A Two-Sample Mendelian Randomization Study
by: Kiwon Kim, et al.
Published: (2021-08-01)

Somatic transposition in the brain has the potential to influence the biosynthesis of metabolites involved in Parkinson’s disease and schizophrenia
by: Abrusán György
Published: (2012-11-01)

Roles of the Functional Interaction between Brain Cholinergic and Dopaminergic Systems in the Pathogenesis and Treatment of Schizophrenia and Parkinson’s Disease
by: Srijan Acharya, et al.
Published: (2021-04-01)

Parkinsonism and Belly Dancer Syndrome in a Patient with Schizophrenia
by: Luiz Felipe Vasconcellos, et al.
Published: (2019-07-01)

Medications Used for Cognitive Enhancement in Patients With Schizophrenia, Bipolar Disorder, Alzheimer’s Disease, and Parkinson’s Disease
by: Wen-Yu Hsu, et al.
Published: (2018-04-01)

Psychiatric morbidity in patients with idiopathic Parkinson's disease: A cross-sectional study
by: Santhosh Kumar, et al.
Published: (2021-01-01)

A Response to: "A Commentary on Antipsychotic-induced parkinsonism is associated with working memory deficits in schizophrenia-spectrum disorders.
by: Stephane ePotvin, et al.
Published: (2015-08-01)

Application of deep learning in detecting neurological disorders from magnetic resonance images: a survey on the detection of Alzheimer’s disease, Parkinson’s disease and schizophrenia
by: Manan Binth Taj Noor, et al.
Published: (2020-10-01)

Comorbid Medical Conditions in Schizophrenia
by: Betul Demirel Dongel, et al.
Published: (2017-09-01)

Biological and Clinical Implications of Comorbidities in Parkinson’s Disease
by: Jose A. Santiago, et al.
Published: (2017-12-01)

Incubus syndrome in late-onset schizophrenia
by: Yogender Kumar Malik, et al.
Published: (2019-01-01)

2D-DIGE as a strategy to identify serum protein biomarkers to monitor pharmacological efficacy in dopamine-dictated states of Parkinson’s disease and schizophrenia
by: Gupta AK, et al.
Published: (2019-04-01)

Coping among the caregivers of patients with schizophrenia
by: Sandeep Grover, et al.
Published: (2015-01-01)

Emotional processing in Parkinson’s disease and schizophrenia: Evidence for response bias deficits in PD
by: Ilona Paulina Laskowska
Published: (2015-09-01)

Cerebrospinal Fluid Proteomics For Identification Of α2-Macroglobulin As A Potential Biomarker To Monitor Pharmacological Therapeutic Efficacy In Dopamine Dictated Disease States Of Parkinson’s Disease And Schizophrenia
by: Gupta AK, et al.
Published: (2019-10-01)

Comorbid bipolar depression and dementia managed with electroconvulsive therapy: A case report and review of the evidence
by: Sandeep Grover, et al.
Published: (2017-01-01)

Religion, spirituality, and schizophrenia: A review
by: Sandeep Grover, et al.
Published: (2014-01-01)

Evaluation of α-synuclein and apolipoprotein E as potential biomarkers in cerebrospinal fluid to monitor pharmacotherapeutic efficacy in dopamine dictated disease states of Parkinson’s disease and schizophrenia
by: Gupta AK, et al.
Published: (2019-07-01)

Comorbidity of narcolepsy and schizophrenia: one case report
by: Yan DING, et al.
Published: (2017-09-01)

A Distinct Scenario of a Patient with Parkinson’s Disease and Comorbid Normal Pressure Hydrocephalus
by: Halil Onder
Published: (2020-05-01)

ErbB1-4-dependent EGF/neuregulin signals and their cross talk in the central nervous system: pathological implications in schizophrenia and Parkinson’s disease
by: Yuriko eIwakura, et al.
Published: (2013-02-01)

Marontology: Comorbidities of Homeless People Living with Schizophrenia
by: João Gama Marques, et al.
Published: (2020-04-01)

Association of Dopamine Beta-Hydroxylase Polymorphisms with Alzheimer’s Disease, Parkinson’s Disease and Schizophrenia: Evidence Based on Currently Available Loci
by: Siqi Tang, et al.
Published: (2018-11-01)

Physical comorbidity in schizophrenia & its correlates
by: K N Nishanth, et al.
Published: (2017-01-01)

Substance Use Disorder Comorbidity in Schizophrenia
by: Hatice İmer Aras
Published: (2013-09-01)

Peculiarities of clinical development of schizophrenia with comorbid somatic disorders.
by: Ye. V. Oprya
Published: (2018-06-01)

Early trauma, attachment experiences and comorbidities in schizophrenia
by: Thalita Gabínio, et al.
Published: (2018-04-01)

Metabolic syndrome in schizophrenia
by: Nidhi Malhotra, et al.
Published: (2013-01-01)

Psychiatric aspects of Parkinson’s disease
by: Sandeep Grover, et al.
Published: (2015-01-01)

The study of neurotropic autoantibody levels in patients with epilepsy, Parkinson’s disease and schizophrenia
by: M. V. Baturina, et al.
Published: (2018-02-01)

Possible multiple system atrophy with predominant parkinsonism in a patient with chronic schizophrenia: a case report
by: Hiroshi Komatsu, et al.
Published: (2018-05-01)

Evolution of substance use, neurological and psychiatric symptoms in schizophrenia and substance use disorder patients: a 12-week, pilot, case-control trial with quetiapine
by: Simon eZhornitsky, et al.
Published: (2011-05-01)

The effect of idiopathic Parkinson's disease on seated trunk reactions
by: Pauhl, Katherine Elizabeth
Published: (2008)

The effect of idiopathic Parkinson's disease on seated trunk reactions
by: Pauhl, Katherine Elizabeth
Published: (2008)

The effect of idiopathic Parkinson's disease on seated trunk reactions
by: Pauhl, Katherine Elizabeth
Published: (2008)

A comparative study of caregiver burden and stigma among the caregivers of patients with dementia and schizophrenia
by: Shaheena Parveen, et al.
Published: (2021-01-01)

Cannot write session to /tmp/vufind_sessions/sess_lk05lbjnk6flvt3j0ha116dsqe